.jpeg)
Where to buy satlizumab (Anshiping)? Have you entered the hospital?
Satralizumab, currently approved in more than 60 countries, is the first and only subcutaneous drug for adults and adolescents with anti-aquaporin-4 (AQ P4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), as monotherapy or in combination with immunosuppressants. Satrolizumab, which is marketed in China, is sold under the brand name Anshiping and is covered by medical insurance. It is only reimbursed for patients who meet the indications. Domestic hospitals may sell this drug, but patients must obtain the drug with a doctor's prescription. For specific prices and drug information of overseas drugs, please consult Yaode Medical Consultant.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
